Tọrọ ntọala na 2009, JYMed bụ a na-eduga peptide CRDMO ọrụ na-eweta na generic API emeputa na China specializing na omenala njikọ, usoro mmepe, clinical ọkọnọ na commercialization nke peptide bekee. Ụlọ ọrụ ahụ na-arụ ọrụ ihe dị ka 600+ FTEs, yana otu ndị isi njikwa nke ndị ọkachamara nwere ahụmahụ karịrị afọ 20 na teknụzụ peptide. JYMed na-arụ ọrụ otu R&D center na abụọ isi multi-nzube mmepụta ụlọ ọrụ, na multi-ton ọnụ ọgụgụ peptide n'ichepụta ikike.
JYMED
ngwaahịa
Ọrụ CRO
Ọrụ CRO
Dị ka ụlọ ọrụ lekwasịrị anya ndị ahịa, JYMed na-enye mmepe peptide zuru oke na ikpo okwu mmepụta ihe na-akwado ihe karịrị afọ 20 nke nka R&D na akụrụngwa ọgbara ọhụrụ. Anyị na-ebuga peptides dị elu ahaziri maka mkpa onye ahịa ọ bụla.
Peptide API
Peptide API
JYMed na-enye nnukwu pọtụfoliyo nke karịrị 20 peptide API, gụnyere Semaglutide, Tirzepatide, Liraglutide, Degarelix, na Oxytocin. Ọtụtụ n'ime ndị a, dị ka Semaglutide na Tirzepatide, emechaala ndebanye aha na ịzụ ahịa nke ọma.
Ọrụ CDMO
Ọrụ CDMO
JYMed na-enye usoro CDMO zuru oke ma dị mma, na-enye ọrụ dị iche iche maka ngwaahịa peptide na peptide-analog. Nke a gụnyere nyocha na mmepụta nke peptides ọgwụgwọ, peptides ọgwụgwọ anụmanụ, na ndị ọzọ.
Peptide ịchọ mma
Peptide ịchọ mma
JYMed na-enye peptides ịchọ mma dị elu, akụrụngwa, na usoro OEM sitere na nyocha ruo ọkwa cGMP - niile n'okpuru njikwa mma. A na-eji peptides sịntetịt akpọrọ ihe maka nchekwa ha, ịdị ọcha na ịdị mfe nke nhazi ha.
GABATARA
JYMED
JYMed bụ onye na-emepụta peptide peptide nke US na-enyocha ọkachamara na peptides ịchọ mma, peptide APIs, na peptides omenala. Ngwaahịa anyị egosipụtara gụnyere Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, na ndị ọzọ. Iji mụtakwuo, biko kpọtụrụ anyị na:
Email: jymed@jymedtech.com
ozi na ozi
Soro JYMed Peptide na Pharmaconex 2025
JYMed Peptide nwere obi ụtọ ịkpọ gị ka ị bịa na Pharmaconex 2025, na-eme site na Septemba 1–3, 2025, na Egypt International Exhibition Center (EIEC) na Cairo. Na-ekpuchi ebe ngosi ihe ngosi nke 12,000+ square mita, ihe omume ahụ ga-anabata ndị ngosi 350+ ma na-atụ anya na ọ ga-adọta 8,000+ professionala ...
Soro JYMed Peptide na CPhI Korea 2025
JYMed Peptide nwere obi ụtọ ịkpọ gị ka ị bịa CPhI Korea 2025, na-eme site na August 26–28, 2025, na COEX Convention & Exhibition Center na Seoul. N'ihe gbasara 15,000 square mita, a na-atụ anya na ihe omume a ga-anabata ihe karịrị 450 ngosi ma nabata ndị ọbịa ọkachamara 10,000. N'afọ 2024...
Soro JYMed na CPHI South East Asia 2025
Anyị nwere obi ụtọ isonyere ndị isi ụlọ ọrụ na CPHI South East Asia 2025, na-eme site na Julaị 16 ruo 18 na MITEC na Kuala Lumpur. Ihe omume a gbasara ihe karịrị 15,000 square mita na ga-egosipụta gburugburu 400 ngosi. A na-atụ anya na ihe karịrị ndị ọkachamara 8,000 ga-aga, yana 60+ seminarị na forums f ...
